Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during the Influenza Season

The summary for the Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during the Influenza Season grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention, which is the U.S. government agency offering this grant.

Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during the Influenza Season: The purpose of the program is to continue the objectives of FOA IP10-007 to determine the effectiveness of empiric influenza antiviral therapy, in addition to empiric antibiotic therapy, for hospitalized CAP patients, and other patients with lower respiratory tract illness, during the periods when influenza viruses are circulating in the community. This program addresses the "Healthy People 2020" focus area(s) of Immunization and Infectious Diseases.

Federal Grant Title:	Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during the Influenza Season
Federal Agency Name:	Centers for Disease Control and Prevention
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	CDC-RFA-IP10-0070201SUPP12
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.185
CFDA Descriptions:	Immunization Research, Demonstration, Public Information and Education_Training and Clinical Skills Improvement Projects
Current Application Deadline:	Aug 10, 2012
Original Application Deadline:	Aug 10, 2012
Posted Date:	Jul 30, 2012
Creation Date:	Jul 30, 2012
Archive Date:	Sep 09, 2012
Total Program Funding:	$846,000
Maximum Federal Grant Award:	$0
Minimum Federal Grant Award:	$0
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: This award will be a continuation of funds intended only for grantee previously awarded under Funding Opportunity Announcement IP10-007, "Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during the Influenza Season" (U18). A third year of patient enrollment is needed to obtain the sample size necessary to meet the objectives of this study. Despite good enrollment during the second year of the study, 2011-12, few influenza infections were identified. Flu activity was low through the U.S. Also, the number of LRTI hospitalizations was lower than previous years. An additional year would allow a larger sample size. Based on past performance, if current enrollment rates continue and there is 10-15% influenza, sample size will be met.
Grant Announcement Contact: CDC Procurement and Grants Office TIMS Phone 770-488-2700

[email protected] [[email protected]]
Similar Government Grants: • Partnerships to Enhance Immunization Information Systems (IIS); • Advancing the capacity of immunization program managers through a national coordinating or...; • Understanding Adult Immunization Quality Improvement Approaches Among Adult HCP and Health...; • Developing a Public Health Tool to Predict the Virality of Vaccine Misinformation Narrativ...; • Collaborative Surveys to Provide Inputs into Vaccine-Related Economic Evaluations; • Coordination of Activities Between the CDC's National Immunization Program and the State a...; • National Minority Organizations Immunization Projects; • Using Provider Partnerships to Strengthen the Immunization Message
More Grants from the Centers for Disease Control and Prevention: • Advancing Diagnostic Network Optimization, Stepwise Laboratory Accreditation, and Integrat...; • Strengthening Public Health Systems and Services through National Partnerships to Improve ...; • 93.067; • Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities o...; • Technical Assistance to Support Comprehensive Combination HIV Prevention, Care and Treatme...